| Abstract |
This chapter deals with the approved and marketed anticancer drugs derived from marine sponges, mollusks/cyanobacteria, and tunicates; marine biota-derived anticancer compounds in clinical trials i.e in III, II, and I phases; and bioactive new chemical entities (NCEs) with anticancer function from marine biota. Limiting factors in the development and approval of drugs from marine biota and significant challenges in the development and approval of marine drugs are also given. |
| Authors |
Ramasamy Santhanam , Santhanam Ramesh , Subbiah Balasundari , Sheba R. David  
|
| Journal Info |
BENTHAM SCIENCE PUBLISHERS eBooks | Anticancer Drugs Sourced from Marine Life , pages: 20 - 45
|
| Publication Date |
8/5/2024 |
| ISSN |
|
Type |
book-chapter |
| Open Access |
closed
|
| DOI |
https://doi.org/10.2174/9789815256055124010005 |
| Keywords |
Biota (Score: 0.8817986) , Anticancer drug (Score: 0.6691805) , Limiting (Score: 0.5835944) , Bioprospecting (Score: 0.4802135)
|
